Saving Lives: Canada''s Implementation of the Doha Declaration


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 3,651

Availability: Out of stock


Delivery :

Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

Pharmaceutical product patents have recently become the focus of attention for health activists and governments worldwide, largely because of their direct effect on people''s lives and survival; particularly the thousands suffering from HIV/AIDS. On 30 August 2003, pursuant to the adoption of the Doha Declaration on TRIPs Agreement and Public Health [14/11/01], the WTO Council for TRIPs met to find a solution to the difficulty faced by countries with insufficient or no capacity to manufacture drugs. It was resolved that developed countries could now issue compulsory licenses for purposes of exporting HIV/AIDS drugs to developing countries. Prior to this resolution, compulsorily licensed products were restricted only to the domestic market of the country issuing the license. Canada became the first developed country to take the bold step of pledging that they will amend their patent laws for purposes of providing drugs to developing countries. This paper analyses the possible implications of Canada''s decision with respect to other developed countries, drug manufacturers, and the future of international patent protection generally.

Product Specifications
SKU :COC31866
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
0 Review(s)